Evidera
Karen Bailey, PhD, is a seasoned research scientist currently at Evidera, with a robust background in health research and patient-centered outcomes. Previously, Karen served as Associate Director and UK lead at OPEN Health Evidence & Access, where significant roles included Senior Patient Centred Outcomes Consultant. With experience as an Independent Consultant and a PhD candidate at King’s College London, Karen has designed and carried out impactful studies, producing peer-reviewed publications and delivering comprehensive evaluations. Prior to these roles, Karen held leadership positions at organizations such as AVA and London's action Trust, focusing on strategic planning, governance, and multi-agency projects related to domestic violence and health services. Karen's academic credentials include a PhD in Addictions Science and a Master's in Mental Health Services and Population Research from King's College London, alongside various degrees in human rights and philosophy.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.